SVR associated with lower risk for diabetes in HCV

ORLANDO, Fla. — Patients with hepatitis C who achieve a sustained virologic response after treatment have a lower risk of developing type 2 diabetes, according to research presented here at Digestive Disease Week.

Hyder and colleagues used data from the Veterans Affairs Clinical Case Registry to identify patients with HCV, without pre-existing diabetes, who initiated antiviral treatment between 1998 and 2007. They evaluated the incidence of diabetes among patients who achieved sustained virologic response (SVR) and those who did not clear the infection.“There are intrahepatic factors and extrahepatic factors that link diabetes and HCV,” Sarah Hyder, MD, a gastroenterology fellow at Brown University, told Infectious Disease News. “Considering this link, we postulated that successful treatment of HCV could decrease the risk for new-onset diabetes in these patients.”

Read More -  SVR associated with lower risk for diabetes in HCV